{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:54:22Z","timestamp":1789872862779,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1615,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/jto.0b013e31821ea5f7","type":"journal-article","created":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T13:00:32Z","timestamp":1308142832000},"page":"S1749-S1755","source":"Crossref","is-referenced-by-count":84,"special_numbering":"S3","title":["Chemotherapy Definitions and Policies for Thymic Malignancies"],"prefix":"10.1016","volume":"6","author":[{"given":"Nicolas","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Wakelee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Riely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Loehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e31821ea5f7_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/JTO.0b013e31818e105c","article-title":"Thymoma: a focus on current therapeutic management","volume":"4","author":"Girard","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.1990.8.8.1419","article-title":"Chemotherapy of invasive thymoma","volume":"8","author":"Fornasiero","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib3","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0003-4975(03)01020-8","article-title":"Long-term outcome after multimodality treatment for stage III thymic tumors","volume":"76","author":"Venuta","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.athoracsur.2004.12.047","article-title":"Advanced stage thymomas and thymic carcinomas: results of multimodality treatments","volume":"79","author":"Lucchi","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.coc.0000138963.01562.d3","article-title":"Multimodality treatment program in invasive thymic epithelial tumor","volume":"28","author":"Jacot","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(19)34092-9","article-title":"Chemotherapy and operation for invasive thymoma","volume":"106","author":"Rea","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2003.09.022","article-title":"Multimodal management of stages III-IVa malignant thymoma","volume":"44","author":"Bretti","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/JTO.0b013e31802bafc8","article-title":"Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone","volume":"2","author":"Yokoi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","article-title":"Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors","volume":"85","author":"Wright","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib12","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib13","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/jco.2008.26.15_suppl.8018","article-title":"A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma: E1C99","volume":"26","author":"Lemma","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H","article-title":"Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma","volume":"68","author":"Macchiarini","year":"1991","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/oxfordjournals.annonc.a058527","article-title":"Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients","volume":"4","author":"Berruti","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605731","article-title":"A phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)","volume":"103","author":"Kunitoh","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib18","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bjc.6690773","article-title":"Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience","volume":"81","author":"Berruti","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000421-199308000-00014","article-title":"EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma","volume":"16","author":"Bonomi","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib21","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1999.17.9.2737","article-title":"Treatment of invasive thymoma with single-agent ifosfamide","volume":"17","author":"Highley","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib22","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1097\/JTO.0b013e3181f13682","article-title":"Standard outcome measures for thymic malignancies","volume":"5","author":"Huang","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.1984.2.11.1281","article-title":"The importance of dose intensity in chemotherapy of metastatic breast cancer","volume":"2","author":"Hryniuk","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archneur.57.4.527","article-title":"Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia","volume":"57","author":"Mygland","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2008.03.004","article-title":"Thymoma, myasthenia gravis, and other paraneoplastic syndromes","volume":"22","author":"Tormoehlen","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib28","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga Stage Classification for thymic malignancies: clarification and definition of terms","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib29","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib30","doi-asserted-by":"crossref","first-page":"S1743","DOI":"10.1097\/JTO.0b013e31821ea60c","article-title":"Radiation therapy definitions and reporting guidelines for thymic malignancies","volume":"6","author":"Gomez","year":"2011","journal-title":"J Thoracic Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-8140(94)01493-M","article-title":"Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. F\u00e9d\u00e9ration Nationale des Centres de Lutte Contre le Cancer","volume":"34","author":"Cowen","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.7326\/0003-4819-129-2-199807150-00006","article-title":"A multidisciplinary approach to therapy for unresectable malignant thymoma","volume":"129","author":"Shin","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","article-title":"Thymic carcinoma: state of the art review","volume":"59","author":"Eng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib34","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1200\/jco.2006.24.18_suppl.7079","article-title":"A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma","volume":"24","author":"Loehrer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0936-6555(05)80783-6","article-title":"Dramatic response of recurrent invasive thymoma to high doses of corticosteroids","volume":"4","author":"Kirkove","year":"1992","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/mus.880040512","article-title":"Effect of corticosteroids on the thymus in myasthenia gravis","volume":"4","author":"Craven","year":"1981","journal-title":"Muscle Nerve"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib37","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1055\/s-2004-831362","article-title":"Rebound hyperplasia of the thymus with secondary intrathymic bleeding. Rare differential diagnosis of acute chest pain","volume":"129","author":"Gerhardt","year":"2004","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib38","first-page":"67","article-title":"Rebound thymic hyperplasia following high dose chemotherapy and allogeneic BMT","volume":"11","author":"Miniero","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-2008-1047021","article-title":"Computed tomographic detection of chemotherapy-induced thymus changes in patients with metastatic testicular tumors","volume":"150","author":"Hendrickx","year":"1989","journal-title":"Rofo"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib40","first-page":"325","article-title":"The thymus: a comprehensive review","volume":"26","author":"Nishino","year":"2005","journal-title":"Radiographics"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12149-009-0283-z","article-title":"Characterization of thymic masses using (18)F-FDG PET-CT","volume":"23","author":"Kumar","year":"2009","journal-title":"Ann Nucl Med"},{"key":"10.1097\/JTO.0b013e31821ea5f7_bib42","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2214\/ajr.180.5.1801265","article-title":"Characterization of the normal and hyperplastic thymus on chemical-shift MR imaging","volume":"180","author":"Takahashi","year":"2003","journal-title":"AJR Am J Roentgenol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415329026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415329026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T04:52:42Z","timestamp":1592628762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415329026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1556086415329026"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e31821ea5f7","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}